Metastatic renal cell carcinoma: Synchronous vs. metachronous metastatic disease and its impact on cancer control in the IO-combination era—Real world experiences from a multi-institutional cohort

This study examined the impact of when metastases occur on survival outcomes in kidney cancer patients treated with first-line immune-combination therapies. The findings show that a longer interval before the development of metastases is associated with better outcomes.

Authors

Institutions

Publication Details

Journal
Urologic Oncology Seminars and Original Investigations
Published
2025-05-20
DOI
https://doi.org/10.1016/j.urolonc.2025.04.004
Citations
1
Primary Topic
Renal cell carcinoma treatment
Type
article
Field-Weighted Citation Impact
1.52
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Metastatic renal cell carcinoma: Synchronous vs. metachronous metastatic disease and its impact on cancer control in the IO-combination era—Real world experiences from a multi-institutional cohort

Alexander Cox, Charis Kalogirou, Friedemann Zengerling, Oliver Hãhn et al.
1 citations
Urologic Oncology Seminars and Original Investigations
Renal cell carcinoma treatment
1.52
article

Metastatic renal cell carcinoma: Synchronous vs. metachronous metastatic disease and its impact on cancer control in the IO-combination era—Real world experiences from a multi-institutional cohort

Alexander Cox, Charis Kalogirou, Friedemann Zengerling, Oliver Hãhn, Luka Flegar, Jonathan Vollemaere, Jörg Ellinger, Marcus Sondermann, Philipp Schmucker, Séverine Banek, Philip Zeuschner, Angelika Mattigk, Cristina Cano Garcia, Niklas Klümper, Johannes Huber, Benedikt Hoeh, Kati Erdmann
article en
1 citations

Abstract

This study examined the impact of when metastases occur on survival outcomes in kidney cancer patients treated with first-line immune-combination therapies. The findings show that a longer interval before the development of metastases is associated with better outcomes.

Urologic Oncology Seminars and Original InvestigationsVol. 43(9)
Goethe University Frankfurt (DE), Philipps University of Marburg (DE), University of Würzburg (DE), University Hospital Bonn (DE), University Medical Center Freiburg (DE), University Hospital Frankfurt (DE), University Hospital Ulm (DE), University Hospital Carl Gustav Carus (DE), Technische Universität Dresden (DE), Saarland University (DE)
Openalex Percentile: Top 18%
Renal cell carcinoma treatment
1.52
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.